According to ASLAN Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.754227. At the end of 2023 the company had a P/S ratio of 2.61.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.61 | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | -100% |
2019 | 25.7 | |
2018 | N/A |